The overall goal of this academic-industrial partnership between researchers at Johns Hopkins University and Philips Healthcare/Philips Research is to develop and optimize the novel amide proton transfer (APT) imaging technique for efficient and reliable detection of malignant brain tumors and assessment of treatment response. APT imaging can provide endogenous contrast related to mobile protein content in tissue. Preclinical studies and clinical data suggest that APT imaging may provide unique information about the presence and grade of brain tumors, as revealed by MRI-guided proteomics and in vivo MR spectroscopy. Notably, we recently demonstrated in animal models that the APT-MRI signal is a unique imaging biomarker to distinguish between radiation necrosis and active tumor tissue. Similar to other MRI techniques, the ultimate goal for APT imaging is the standardized use in a clinical setting. However, current APT imaging protocols are far from being optimized. A main reason is that the APT experimental parameters are often limited by scanner hardware constraints, particularly with respect to amplifier duty-cycle and specific absorption rate requirements. In addition to pulse sequence parameter differences, leading to inconsistent effect sizes, data processing strategies vary and may affect the reproducibility of results between hospitals. Therefore, there is an urgent need for industry and academia to work together to develop this emerging technology into a clinically viable, easy-to-use, and reproducible approach. To accomplish this, we (researchers at JHU and Philips) agreed to establish a cooperation to achieve an accelerated APT translation. Together, we formulated the following two specific aims: (1) Optimize and standardize APT imaging technology on 3T human MRI systems;and (2) Test the methodologies developed in Aim 1 on patients with brain tumors. APT imaging has the potential to introduce an entirely new molecular MRI methodology into the clinic that can detect endogenous cellular protein signals in biological tissue non-invasively. Thi research will provide the standard optimized approaches required to translate this new technology into the clinic.
The overall goal of this academic-industrial partnership is to optimize a novel MR molecular imaging technique, called amide proton transfer imaging, for efficient and reliable detection of malignant brain tumors on 3T human MRI scanners. If successful, we expect to provide an entirely new and optimized whole-brain imaging technology that can reliably identify the spatial extent of high grade tumors non-invasively, for both contras-enhancing and non-enhancing gliomas. This specific MRI modality is expected to aid in the diagnosis and treatment of brain tumors, directly impacting patient care.
|Lu, Jianhua; Zhou, Jinyuan; Cai, Congbo et al. (2015) Observation of true and pseudo NOE signals using CEST-MRI and CEST-MRS sequences with and without lipid suppression. Magn Reson Med 73:1615-22|
|Zhang, Yi; Zhou, Jinyuan; Bottomley, Paul A (2015) Minimizing lipid signal bleed in brain (1) H chemical shift imaging by post-acquisition grid shifting. Magn Reson Med 74:320-9|
|Hong, Xiaohua; Liu, Li; Wang, Meiyun et al. (2014) Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat model. Neuro Oncol 16:856-67|
|Li, Chunmei; Peng, Shuai; Wang, Rui et al. (2014) Chemical exchange saturation transfer MR imaging of Parkinson's disease at 3 Tesla. Eur Radiol 24:2631-9|
|Lu, Jianhua; Cai, Congbo; Cai, Shuhui et al. (2014) Chemical exchange saturation transfer MRI using intermolecular double-quantum coherences with multiple refocusing pulses. Magn Reson Imaging 32:759-65|
|Yuan, Jing; Chen, Shuzhong; King, Ann D et al. (2014) Amide proton transfer-weighted imaging of the head and neck at 3?T: a feasibility study on healthy human subjects and patients with head and neck cancer. NMR Biomed 27:1239-47|
|Xu, Jiadi; Yadav, Nirbhay N; Bar-Shir, Amnon et al. (2014) Variable delay multi-pulse train for fast chemical exchange saturation transfer and relayed-nuclear overhauser enhancement MRI. Magn Reson Med 71:1798-812|
|Jones, Craig K; Huang, Alan; Xu, Jiadi et al. (2013) Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T. Neuroimage 77:114-24|
|Zhou, Jinyuan; Hong, Xiaohua; Zhao, Xuna et al. (2013) APT-weighted and NOE-weighted image contrasts in glioma with different RF saturation powers based on magnetization transfer ratio asymmetry analyses. Magn Reson Med 70:320-7|
|Zhang, Yi; Gabr, Refaat E; Zhou, Jinyuan et al. (2013) Highly-accelerated quantitative 2D and 3D localized spectroscopy with linear algebraic modeling (SLAM) and sensitivity encoding. J Magn Reson 237:125-38|